|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 169.64 USD | -0.99% |
|
+0.22% | +84.53% |
| 07-31 | EU Approves AstraZeneca and Daiichi Sankyo's Datroway for First-Line Triple-Negative Breast Cancer | MT |
| 07-31 | Astrazeneca, Daiichi Sankyo's Breast Cancer Therapy Receives EU approval | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,024B | |||||
| 618B | |||||
| 443B | |||||
| 349B | |||||
| 297B |
Select your edition
All financial news and data tailored to specific country editions
